rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2008-3-4
|
pubmed:abstractText |
Though effective anti-human immunodeficiency virus (HIV) therapies are now available, they have variable penetration into the brain. We therefore aimed to assess changes over calendar time in the risk for HIV-associated dementia (HIV-D), and factors associated with HIV-D risk.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1531-8249
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
63
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
213-21
|
pubmed:meshHeading |
pubmed-meshheading:17894380-AIDS Dementia Complex,
pubmed-meshheading:17894380-Adult,
pubmed-meshheading:17894380-Age Factors,
pubmed-meshheading:17894380-Age of Onset,
pubmed-meshheading:17894380-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:17894380-CD4 Lymphocyte Count,
pubmed-meshheading:17894380-Disease Progression,
pubmed-meshheading:17894380-Europe,
pubmed-meshheading:17894380-Female,
pubmed-meshheading:17894380-HIV Infections,
pubmed-meshheading:17894380-HIV Seropositivity,
pubmed-meshheading:17894380-Homosexuality, Male,
pubmed-meshheading:17894380-Humans,
pubmed-meshheading:17894380-Incidence,
pubmed-meshheading:17894380-Male,
pubmed-meshheading:17894380-Middle Aged,
pubmed-meshheading:17894380-Prognosis,
pubmed-meshheading:17894380-Proportional Hazards Models,
pubmed-meshheading:17894380-Risk Factors,
pubmed-meshheading:17894380-Risk-Taking,
pubmed-meshheading:17894380-Severity of Illness Index,
pubmed-meshheading:17894380-Sexual Behavior,
pubmed-meshheading:17894380-Survival Analysis,
pubmed-meshheading:17894380-Time Factors,
pubmed-meshheading:17894380-Viral Load
|
pubmed:year |
2008
|
pubmed:articleTitle |
Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy.
|
pubmed:affiliation |
Medical Research Council Clinical Trials Unit, London, United Kingdom.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|